4Front Ventures (4Front Ventures) Growth Rank : 3 (As of Apr. 28, 2024)

View and export this data going back to 2010. Start your Free Trial

What is 4Front Ventures Growth Rank?

4Front Ventures has the Growth Rank of 3.

GuruFocus Growth Rank measures the growth of a company in terms of its revenue and profitability. Historically, the companies with the highest growth ranks performed the best over the long term. It is calculated using the following criteria:

1. 5-year revenue growth rate, the higher, the better.
2. 3-year revenue growth rate, the higher, the better.
3. 5-year EBITDA growth rate, the higher, the better.
4. The predictability of 5-year revenue. The most consistent it is, the higher the rank.

GuruFocus found that the Growth Rank is the second of the two most-sensitive parameters among the five parameters checked. Please click GF Score to see more details on GF Score's 5 Key Aspects of Analysis.

Please note that we are using the five-year EBITDA growth rate as a parameter, so the company needs to have had positive growth over that time. The reason we use EBITDA instead of earnings per share is that with EBITDA, we can rank a lot more companies since a company may have positive EBITDA but negative EPS. Since we are looking at the growth here, EBITDA gives us a pretty clear picture about the growth in the company's business operations.

Competitive Comparison of 4Front Ventures's Growth Rank

For the Drug Manufacturers - Specialty & Generic subindustry, 4Front Ventures's Growth Rank, along with its competitors' market caps and Growth Rank data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

4Front Ventures's Growth Rank Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, 4Front Ventures's Growth Rank distribution charts can be found below:

* The bar in red indicates where 4Front Ventures's Growth Rank falls into.

4Front Ventures Growth Rank Related Terms

Thank you for viewing the detailed overview of 4Front Ventures's Growth Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

4Front Ventures (4Front Ventures) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » 4Front Ventures Corp (OTCPK:FFNTF) » Definitions » Growth Rank

Comparable Companies

Traded in Other Exchanges

FFNT:Canada

Address

5060 North 40th Street, Suite 120, Phoenix, AZ, USA, 85018

Website

https://www.4frontventures.com

4Front Ventures Corp is a Canadian-based company. It is engaged in the cultivation, processing, extracting, manufacturing, and distribution of cannabis products. It operates in two segments: THC Cannabis and CBD Wellness. The THC Cannabis segment engages in the production and cultivation of THC cannabis, manufacturing and distribution of cannabis products to own dispensaries and third-party retail customers. The CBD Wellness segment encompasses the production and sale of CBD products to third-party customers.

Executives

Leonid Gontmakher	director, officer: Chief Executive Officer	5060 N. 40TH STREET, SUITE 120, PHOENIX AZ 85018
Nicole Frederick	officer: See Remarks	C/O 4FRONT VENTURES CORP., 7010 E. CHAUNCEY LANE STE. 235, PHOENIX AZ 85054
Kristopher Krane	director	5060 N. 40TH STREET, SUITE 120, PHOENIX AZ 85018
David Ryan Daily	director	5060 N 40TH STREET STE 120, PHOENIX AZ 85018
Roman Tkachenko	director	5060 N 40TH STREET STE 120, PHOENIX AZ 85018
Karl Chowscano	other: Consultant	5060 N. 40TH STREET, SUITE 120, PHOENIX AZ 85018
Chetan Gulati	director	28 REICHERT CIRCLE, WESTPORT CT 06880
Keith Edward Adams	officer: Chief Financial Officer	108 S. WETHERLY DRIVE, UNIT 4, LOS ANGELES CA 90048
Robert E Hunt	director	C/O GROWLIFE, INC., 20301 VENTURA BLVD., SUITE 126, WOODLAND HILLS CA 91364
Amit Ramanlal Patel	director	3305 PINE AVENUE, MANHATTAN BEACH CA 90266
Kathi P Lentzsch	director	5060 N 40TH STREET STE 120, PHOENIX AZ 85018
Andrew Thut	officer: Chief Investment Officer	5060 N. 40TH STREET, SUITE 120, PHOENIX AZ 85018
Joseph R Feltham	officer: Chief Operating Officer	5060 N. 40TH STREET, STE 120, PHOENIX AZ 85018
Eric J. Rey	director	ARCADIA BIOSCIENCES, INC., 202 COUSTEAU PLACE, SUITE 105, DAVIS CA 95618
Nicolle Dorsey	officer: Chief Financial Officer	C/O REAL GOODS SOLAR, INC., 110 16TH STREET, 3RD FLOOR, DENVER CO 80202